Story perspectives

Oz Launches $50 Medicare GLP-1 Pilot, Ends 2027

7/2/2026

Summary

Oz Launches GLP-1

Dr. Mehmet Oz launched a $50-per-month GLP-1 initiative on July 1, 2026 with Foundayo, Zepbound KwikPens and Wegovy.
Eligibility requires Medicare coverage and BMI >= 35 (or >= 27 with a condition) while excluding sleep apnea, diabetes, fatty liver disease.
The $50 fee does not affect deductibles or out-of-pocket maximums, with the pilot set to end Dec. 31, 2027.
Gloria Dralla of California reports weight loss while Katie Smith of Virginia fears ineligibility and $700-per-month costs elsewhere.

Summary

Experts Warn

Experts warn GLP-1 drugs may cause loss of muscle mass in older adults.
Elbert Huang of the University of Chicago says uncertainty is treatment duration and warns the pilot’s temporary nature may jeopardize weight maintenance after 2027.
John Batsis of the University of North Carolina advises GLP-1 treatment be combined with diet, exercise and nutrition.
Pharmacy trade groups warn limited inventories and a mid-year launch could delay access.

Summary

Officials Secure Pricing

Officials secured a $250 price from Eli Lilly and Novo Nordisk, letting beneficiaries pay a $50 copay not counting toward deductibles.
The Congressional Budget Office estimated lifting Medicare’s obesity-drug ban would add $35 billion over nine years.
A University of Chicago study projected GLP-1 coverage would cost $66 billion and net $48 billion in spending in ten years.
Eli Lilly and Novo Nordisk invested billions, Eli Lilly joining an FDA pilot to speed approvals.

1 of 3

Oz Launches GLP-1

Dr. Mehmet Oz launched a $50-per-month GLP-1 initiative on July 1, 2026 with Foundayo, Zepbound KwikPens and Wegovy.
Eligibility requires Medicare coverage and BMI >= 35 (or >= 27 with a condition) while excluding sleep apnea, diabetes, fatty liver disease.
The $50 fee does not affect deductibles or out-of-pocket maximums, with the pilot set to end Dec. 31, 2027.
Gloria Dralla of California reports weight loss while Katie Smith of Virginia fears ineligibility and $700-per-month costs elsewhere.

1 / 3